Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

888.0500 1.50 (0.17%)

NSE Apr 29, 2025 15:31 PM

32.94% Fall from 52W High

Volume: 1.0M

Zydus Lifesciences Ltd.

18 Mar 2025

888.05

0.17%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg.

More from Zydus Lifesciences Ltd.

Recommended

Five stocks to buy from analysts this week - April 29, 2025

The Baseline | 29 Apr 2025, 04:57PM

Market closes flat, TVS Motor's revenue beats Forecaster estimates by 2% in Q4FY25

Trendlyne Marketwatch | 29 Apr 2025, 03:53PM

Earnings Call Transcript - Cadila Healthcare